DDInter187 DDInter1082
A sympathomimetic agent with properties similar to dextroamphetamine. It is used in the treatment of obesity. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1222)
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Benzphetamine {u} (Compound) resembles {v} (Compound) Metamfetamine
Benzphetamine {u} (Compound) resembles {v} (Compound) Amphetamine
Benzphetamine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Promethazine
Benzphetamine {u} (Compound) treats {v} (Disease) obesity
Benzphetamine {u} (Compound) binds {v} (Gene) SLC18A2
Benzphetamine {u} (Compound) is included by {v} (Pharmacologic Class) Increased Sympathetic Activity
Benzphetamine {u} (Compound) causes {v} (Side Effect) Headache
Benzphetamine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Lindane
Benzphetamine {u} may lead to a major life threatening interaction when taken with {v} Bupropion
Benzphetamine {u} may lead to a major life threatening interaction when taken with {v} Phentermine
Benzphetamine (Compound) resembles Metamfetamine (Compound)
Benzphetamine (Compound) resembles Amphetamine (Compound)
Benzphetamine may cause a moderate interaction that could exacerbate diseases when taken with Promethazine
Benzphetamine (Compound) treats obesity (Disease)
Benzphetamine (Compound) binds SLC18A2 (Gene)
Benzphetamine (Compound) is included by Increased Sympathetic Activity (Pharmacologic Class)
Benzphetamine (Compound) causes Headache (Side Effect)
Benzphetamine may cause a moderate interaction that could exacerbate diseases when taken with Lindane
Benzphetamine may lead to a major life threatening interaction when taken with Bupropion
Benzphetamine may lead to a major life threatening interaction when taken with Phentermine